Document View > Cytomegalovirus antigen assay

Cytomegalovirus antigen assay

Cytomegalovirus antigen assay

Cytomegalovirus antigen assay

Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients. 49(RR10). Morbidity and Mortality Weekly Report. Alanta, Georgia, US. 2000. Available from URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm. As accessed 7-26-05.

Salmon-Ceron D, Mazeron MC, Chaput S, et al: Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS 2000; 14:1041-1049.

Osarogiagbon RU, Defor TE, Weisdorf MA, et al: CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biology of Blood and Marrow Transplantation 2000; 6:280-288.

Chiaramonte S, Pellizzer G, Rassu M, et al: Role of antigenemia assay in the early diagnosis and treatment of CMV infection in renal transplant patients. Clinical Nephrology 2000; 53(4):10-12.

Boeckh M, Gallez-Hawkins GM, Myerson D, et al: Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplant 1997; 64(1):108- 113.

Bonin P, Tanino T, Handsfield H, et al: Isolation of Neisseria gonorrhoeae on selective and nonselective media in a sexually transmitted disease clinic. J Clin Microbiol 1984; 19:218-220.

Rawlinson WD: Broadsheet. Number 50: Diagnosis of human cytomegalovirus infection and disease. Pathology 1999; 31(2):109-115.